title: The US Food and Drug Administration's Sentinel Initiative: expanding the horizons of medical product safety.
authors.affiliation: Office of Medical Policy, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD 20993, USA. Melissa.Robb@fda.hhs.gov
authors.forename: Melissa A
authors.initials: MA
authors.lastname: Robb
authors.forename: Judith A
authors.initials: JA
authors.lastname: Racoosin
authors.forename: Rachel E
authors.initials: RE
authors.lastname: Sherman
authors.forename: Thomas P
authors.initials: TP
authors.lastname: Gross
authors.forename: Robert
authors.initials: R
authors.lastname: Ball
authors.forename: Marsha E
authors.initials: ME
authors.lastname: Reichman
authors.forename: Karen
authors.initials: K
authors.lastname: Midthun
authors.forename: Janet
authors.initials: J
authors.lastname: Woodcock
mesh_terms: D016907:Adverse Drug Reaction Reporting Systems; D001688:Biological Products / Q000009:adverse effects; D016208:Databases, Factual; D064420:Drug-Related Side Effects and Adverse Reactions; D004864:Equipment and Supplies / Q000009:adverse effects; D006801:Humans; D010865:Pilot Projects; D011358:Product Surveillance, Postmarketing / Q000379:methods*; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D001688:Biological Products